# FDA Inspection 1061151 - Biomat USA, Inc. - July 16, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/fc34e813-0ada-4f82-876e-159db1deabde/
Source feed: FDA_Inspections

> FDA Inspection 1061151 for Biomat USA, Inc. on July 16, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1061151
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-07-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 920516 - 2015-03-26](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/cb80ffec-72fd-4939-971e-b9c5e9178815/)
- [FDA Inspection 893666 - 2014-08-20](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/fca9cba0-8ebb-4c2f-bc8e-5d4044f5bafe/)
- [FDA Inspection 773242 - 2012-03-21](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/79ec963d-d1ea-40bd-a90b-8fe8f26b3241/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/3e01ec90-2d33-4079-9b0a-6caba04b5934

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d